Cardiocommand, Inc.: FDA filings under this applicant name
FDA lists 0 510(k) clearances under the applicant name “Cardiocommand, Inc.”, plus 1 PMA decision, across 1 product code in 1 review panel. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LPA | System, Esophageal Pacing | 1 | 0 |
Review panels
- Cardiovascular (1)
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P840002 | PMA | STAT-PACE II | 1986-04-30 |
Recalls
5 product recalls in 4 recall events; 0 initiated in the last five years. Most recent: 2019-06-24.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Frequently asked questions
How many FDA 510(k) clearances are listed under Cardiocommand, Inc.?
FDA lists 0 510(k) clearances under the applicant name “Cardiocommand, Inc.”, plus 1 PMA decision, across 1 product code in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
Which FDA product codes appear under Cardiocommand, Inc.?
The most frequent FDA product codes under this applicant name are LPA (System, Esophageal Pacing, 1).
Next steps
- See all 0 Cardiocommand, Inc. clearances with predicates and recalls
- Run predicate analysis for product code LPA, Cardiocommand, Inc.'s most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name (spelling variants such as punctuation and legal suffixes combined); filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.